FSTX - F-star Therapeutics EPS beats by $0.06 misses on revenue November, 10 2021 08:20 AM F-star Therapeutics Inc Com F-star Therapeutics (NASDAQ:FSTX): Q3 GAAP EPS of -$0.52 beats by $0.06. Revenue of $0.75M (-91.8% Y/Y) misses by $1.94M. Press Release For further details see: F-star Therapeutics EPS beats by $0.06, misses on revenue